Reactogenicity to COVID-19 vaccination in the United States of America.

Sanyaolu, Adekunle; Marinkovic, Aleksandra; Prakash, Stephanie; Desai, Priyank; Haider, Nafees; Abbasi, Abu Fahad; Mehraban, Nasima; Jain, Isha; Ekeh, Amarachi; Shazley, Omar; Okorie, Chuku; Orish, Verner N

Sanyaolu, Adekunle; Marinkovic, Aleksandra; Prakash, Stephanie; Desai, Priyank; Haider, Nafees; Abbasi, Abu Fahad; Mehraban, Nasima; Jain, Isha; Ekeh, Amarachi; Shazley, Omar; Okorie, Chuku; Orish, Verner N.

Afiliación

Sanyaolu A; Federal Ministry of Health, Abuja, Nigeria.
Marinkovic A; Saint James School of Medicine, Anguilla, British West Indies.
Prakash S; Saint James School of Medicine, Anguilla, British West Indies.
Desai P; American University of Saint Vincent School of Medicine, Kingstown, Saint Vincent and the Grenadines.
Haider N; All Saints University School of Medicine, Roseau, Dominica.
Abbasi AF; Loyola University Medical Center, Maywood, IL, USA.
Mehraban N; Saint James School of Medicine, Anguilla, British West Indies.
Jain I; Windsor University School of Medicine, Cayon, Saint Kitts and Nevis.
Ekeh A; Avalon University School of Medicine, Willemstad, Curacao.
Shazley O; Saint James School of Medicine, Arnos Vale, St. Vincent and the Grenadines.
Okorie C; Union County College (Plainfield Campus), Plainfield, NJ, USA.
Orish VN; University of Health and Allied Sciences, Ho, Ghana.

Clin Exp Vaccine Res ; 11(1): 104-115, 2022 Jan.

Article en En | MEDLINE | ID: mdl-35223671

Palabras clave

COVID-19; Injection site reaction; SARS-CoV-2; Safety; Vaccination

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Clin Exp Vaccine Res Año: 2022 Tipo del documento: Article País de afiliación: Nigeria